C3 Nephropathy

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-02-19
Clinical Trial Update: Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy [Phase 1]
A Phase 1 trial evaluating eculizumab for dense deposit disease and C3 nephropathy has completed, with results posted in 2019.